Teva Pharmaceutical Industries (TEVA) Return on Equity [ROE] (2009 - 2026)
Teva Pharmaceutical Industries (TEVA) recorded Return on Equity [ROE] of 6.47% in Q3 2026, down 2.93 percentage points from 9.40% a year earlier and down 2.40 percentage points from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Return on Equity [ROE] (2009 - 2026) Analysis & Trends
For FY2025, Teva Pharmaceutical Industries reported Return on Equity [ROE] of 21.33%, up 50.34 percentage points from FY2024.
- Annual Return on Equity [ROE] has a five-year change of +52.71 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Equity [ROE] came in at -29.01% in FY2024 (-21.65 pp), -7.35% in FY2023 (+17.83 pp), -25.19% in FY2022 (-29.28 pp) and 4.09% in FY2021 (+35.47 pp).
- The Q3 2026 figure is the lowest quarterly Return on Equity [ROE] since Q2 2025.
- On a year-over-year basis, Return on Equity [ROE] rose in five of the last eight quarters, with an average year-over-year change of +12.59 percentage points.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 51.99 percentage points in Q4 2025, against a drop of 31.63 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 8.87% (Q2 2026), 19.41% (Q1 2026) and 18.70% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 4.66% |
| 10 | Teva Pharmaceutical Industries | 49.58 Bn | 34.55 Bn | 2.44 Bn | 6.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.47% |
| Jun 30, 2026 | 8.87% |
| Mar 31, 2026 | 19.41% |
| Dec 31, 2025 | 18.70% |
| Sep 30, 2025 | 9.40% |
| Jun 30, 2025 | -2.47% |
| Mar 31, 2025 | -22.65% |
| Dec 31, 2024 | -33.29% |
| Sep 30, 2024 | -18.79% |
| Jun 30, 2024 | -10.62% |
| Mar 31, 2024 | -9.97% |
| Dec 31, 2023 | -7.93% |
| Sep 30, 2023 | -32.25% |
| Jun 30, 2023 | -30.18% |
| Mar 31, 2023 | -21.06% |
| Dec 31, 2022 | -27.62% |
| Sep 30, 2022 | -13.66% |
| Jun 30, 2022 | -10.76% |
| Mar 31, 2022 | -5.40% |
| Dec 31, 2021 | 4.01% |
API Access
Teva Pharmaceutical Industries Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();